Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Non-Current Deffered Revenue (2023)

Baird Medical Investment Holdings has reported Non-Current Deffered Revenue over the past 1 years, most recently at $875258.0 for Q4 2023.

  • For Q4 2023, Non-Current Deffered Revenue changed N/A year-over-year to $875258.0; the TTM value through Dec 2023 reached $875258.0, changed N/A, while the annual FY2023 figure was $875258.0, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q4 2023 was $875258.0 at Baird Medical Investment Holdings.
  • Over five years, Non-Current Deffered Revenue peaked at $875258.0 in Q4 2023 and troughed at $875258.0 in Q4 2023.